Sherehan M. Ibrahim

523 total citations
18 papers, 381 citations indexed

About

Sherehan M. Ibrahim is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sherehan M. Ibrahim has authored 18 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sherehan M. Ibrahim's work include Genomics, phytochemicals, and oxidative stress (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Sherehan M. Ibrahim is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Sherehan M. Ibrahim collaborates with scholars based in Egypt, Saudi Arabia and Poland. Sherehan M. Ibrahim's co-authors include Dalaal M. Abdallah, Marawan A. Elbaset, Noha F. Abdelkader, Heba Salem, Esraa A. Kandil, Hanan S. El‐Abhar, Heba M. A. Abdelrazek, Hala F. Zaki, Ghada A. Badawi and Hebat Allah A. Amin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Archives of Biochemistry and Biophysics.

In The Last Decade

Sherehan M. Ibrahim

15 papers receiving 379 citations

Peers

Countries citing papers authored by Sherehan M. Ibrahim

Since Specialization

Citations

This map shows the geographic impact of Sherehan M. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherehan M. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherehan M. Ibrahim more than expected).

Fields of papers citing papers by Sherehan M. Ibrahim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherehan M. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherehan M. Ibrahim. The network helps show where Sherehan M. Ibrahim may publish in the future.

Co-authorship network of co-authors of Sherehan M. Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Sherehan M. Ibrahim. A scholar is included among the top collaborators of Sherehan M. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherehan M. Ibrahim. Sherehan M. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of SIRT1 / PGC ‐1α and FOXO3a Pathways 2025 ·BioFactors ·(unknown), (unknown), Sherehan M. Ibrahim, (unknown)	0
2	Limettin and PD98059 Mitigated Alzheimer’s Disease Like Pathology Induced by Streptozotocin in Mouse Model: Role of p-ERK1/2/p-GSK-3β/p-CREB/BDNF Pathway 2025 ·Journal of Neuroimmune Pharmacology ·(unknown), Nesma El‐Sayed, Naglaa Assaf, Barbara Budzyńska, Krystyna Skalicka‐Woźniak, Sherehan M. Ibrahim	0
3	Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation 2024 ·Journal of Neuroimmune Pharmacology ·(unknown), Mohammed F. El-Yamany, Sherehan M. Ibrahim	14
4	The preferential effect of Clemastine on F3/Contactin-1/Notch-1 compared to Jagged-1/Notch-1 justifies its remyelinating effect in an experimental model of multiple sclerosis in rats 2024 ·International Immunopharmacology ·Sherehan M. Ibrahim, Ahmed S. Kamel, Kawkab A. Ahmed, (unknown), (unknown)	10
5	Pterostilbene Ameliorates Cognitive Impairment in Polycystic Ovary Syndrome Rat Model through Improving Insulin Resistance via the IRS-1/PI3K/Akt/GSK-3β Pathway: A Comparative Study with Metformin 2024 ·ACS Chemical Neuroscience ·(unknown), (unknown), Sherehan M. Ibrahim, Eman M. Elbaz	5
6	Ubiquinol preserves immune cells in gamma-irradiated rats: Role of autophagy and apoptosis in splenic tissue 2023 ·International Immunopharmacology ·(unknown), (unknown), Sherehan M. Ibrahim, Ramy K. Aziz, Eman Rashad, (unknown)	5
7	Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling 2022 ·Archives of Pharmacal Research ·Noha F. Abdelkader, Marawan A. Elbaset, (unknown), Sherehan M. Ibrahim	35
8	Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats 2022 ·Life Sciences ·(unknown), Ghada A. Badawi, Hala F. Zaki, Sherehan M. Ibrahim	22
9	Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy 2022 ·Archives of Biochemistry and Biophysics ·(unknown), Heba Salem, (unknown), Sherehan M. Ibrahim	15
10	Dimethyl fumarate abridged tauo-/amyloidopathy in a D-Galactose/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK/SIRT-1, AKT/CREB/BDNF, AKT/GSK-3β, adiponectin/Adipo1R, and NF-κB/IL-1β/ROS trajectories 2021 ·Neurochemistry International ·(unknown), Heba M. A. Abdelrazek, Sherehan M. Ibrahim, Dalaal M. Abdallah, Hanan S. El‐Abhar	35
11	Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways 2021 ·Biomedicine & Pharmacotherapy ·Noha F. Abdelkader, Sherehan M. Ibrahim, (unknown), Marawan A. Elbaset	50
12	Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit 2021 ·Frontiers in Endocrinology ·Sherehan M. Ibrahim, (unknown), Carolyn T. Bramante, Surbhi Shah, Nichole R. Klatt, Nancy E. Sherwood, Louis J. Aronne, Michael A. Puskarich, Leonardo Tamariz, Ana Palacio, Eric M. Bomberg, Michael Usher, Samantha King, (unknown), Deneen Vojta, Christopher J. Tignanelli, Nicholas E. Ingraham	41
13	Lutein exerts its cardioprotective effect against the experimental model of isoprenaline‐induced myocardial infarction via MIAT/miR‐200a/Nrf2/TXINP pathway 2021 ·Journal of Biochemical and Molecular Toxicology ·(unknown), Sherehan M. Ibrahim, (unknown), Hebat Allah A. Amin, Mai A. Abd‐Elmawla	18
14	Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways 2020 ·Inflammopharmacology ·Eman M. Elbaz, Hebat Allah A. Amin, Ahmed S. Kamel, Sherehan M. Ibrahim, (unknown)	14
15	Antiulcerogenic effect of melittin via mitigating TLR4/TRAF6 mediated NF-κB and p38MAPK pathways in acetic acid-induced ulcerative colitis in mice 2020 ·Chemico-Biological Interactions ·(unknown), Sherehan M. Ibrahim, Heba Salem, Esraa A. Kandil	46
16	Oxidative Stress and Lipid Profile among Hypertensive Patients at a Tertiary Centre in Kano, Northwest, Nigeria 2019 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hafeez Muhammad Yakasai, Sherehan M. Ibrahim, (unknown)	0
17	Activation of α7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice 2018 ·Scientific Reports ·Sherehan M. Ibrahim, Muhammad Y. Al‐Shorbagy, Dalaal M. Abdallah, Hanan S. El‐Abhar	18
18	Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status 2015 ·PLoS ONE ·Sherehan M. Ibrahim, (unknown), Dalaal M. Abdallah	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact